FAQ

Frequently asked questions about the platform

How does Sentari replace traditional market research vendors?

Sentari isn't a single-shot study tool — it's an always-on engine. The same workflow that delivers your initial brief continues running: refreshing the panel weekly, surfacing new signals, and re-drafting affected artifacts automatically. Your in-house team owns the engine; legacy vendors get consolidated.

Where does the data come from, and is it patient-identifiable?

Claims and EHR streams come from contracted partners with full data-use agreements, and arrive de-identified at the boundary. Primary research transcripts are stored encrypted with PHI redaction applied before any model touches them. Regional residency is enforced for EU and APAC tenants.

What does the human review workflow look like?

Every artifact moves through your configured review gates — medical, legal, regulatory, brand — with one-click annotations linked to the source evidence. You decide which sentinels can act autonomously and which must propose. Nothing leaves the engine without an audit trail.

How long does implementation actually take?

Most pilots are live within 72 hours of contract signing — the engine is multi-tenant by default. Full template configuration (brand voice, dossier formats, review gates, integrations) typically lands in week two, run by our launch engineers alongside your team.

Which therapeutic areas do you cover today?

Sentari is generalist by design — agent moderators and signal taxonomies are reconfigured per indication. Deepest current libraries are in oncology, cardiometabolic, immunology and rare disease, with new TAs added in roughly two-week cycles.

How is pricing structured?

Sentari is priced per study and per seat, with enterprise contracts available for teams running continuous research programs. Book a working session to get a quote scoped to your study volume.
If you have any questions, please contact us